The All Wales Medicines Strategy Group started the assessment of ivacaftor (Kalydeco) as soon as the drug company formally engaged with the appraisal process. This process is recognised to be robust and normally takes about 21 weeks to allow all parties, including patient organisations such as the Cystic Fibrosis Trust, to submit their comments. The final appraisal decision for Kalydeco is scheduled to be reached at a public meeting on 8th May 2013.
More top news
A postman was on his rounds when he noticed a man inside a pensioner's house - police found Neil Williams hiding in the attic.
Susan Wellings suffers from severe pain caused by gallstones but has been left waiting for surgery after doctors refused to operate.
Owain Vaughan, 14, took the drug and was rushed to hospital after suffering severe fits, burst blood vessels and being violently sick.